top of page

23andMe to be acquired by Regeneron Pharmaceuticals

  • Writer: Girls Adoption Connect
    Girls Adoption Connect
  • Jun 8
  • 5 min read

What you need to know about the 23andMe sale


Slide Text


Slide one: 23andMe to be acquired by Regeneron.

What you need to know about the 23andMe sale.

  • 23andMe has agreed to be acquired by Regeneron Pharmaceuticals, a biotechnology company, for $256 million.

  • According to the press release, “23andMe intends to continue operating its business in the ordinary course throughout the sale process.”

  • Regeneron will aquire most of 23andMe’s assets, including its Personal Genome Service (DNA testing) and research divisions.

  • Regeneron has pledged to uphold 23andMe’s existing privacy policies and comply with all applicable data protection laws.

  • A bankruptcy court hearing to consider approval of the transaction is scheduled for June 17. If approved, the deal is expected to close in the third quarter of 2025.

Sources:

“Regeneron to Acquire 23andMe in Court-Supervised Sale,” GlobeNewswire.

23andMe Restructuring & Claims Website.


Slide two: Bankruptcy Claims Notice from 23andMe

When a company files for bankruptcy, they begin a legal process to manage debts and respond to claims.

  • The filing: On March 23, 2025, 23andMe and 11 related companies filed for Chapter 11 bankruptcy. This allows the company to reorganize its debts under court protection.

  • The claims: If you were affected by the October 2023 data breach or believe you’re owed something, you may be eligible to file a claim. Two claim types exist: one for the cyber incident, and one for other general issues.

  • The deadline: July 14, 2025 is the final day to submit your proof of claim. If you don’t file by then, you may lose the right to be part of any payout or settlement in the case.


Slide three: Official Claims Notice from 23andMe


In re: 23andMe Holding Co., et al.,


Chapter 11 – Case No. 25-40976-357 (Jointly Administered)


TO: All Current and Former Customers of 23andMe Holding Co. and its Debtor Subsidiaries (the “Debtors”):



On March 23, 2025, 23andMe Holding Co. and 11 debtor subsidiaries (collectively, the “Debtors”) each filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Eastern District of Missouri, Eastern Division (the “Court”) (seeNotice of Commencement). 


The Court has entered an order (the “Bar Date Order”) setting deadlines (each, a “Bar Date” and collectively, the “Bar Dates”) for filing proofs of claim or requests for payment of certain administrative expenses in these chapter 11 cases.


This notice (the “Notice of Instruction”) is being provided to all current and former customers of 23andMe Holding Co. and its subsidiaries, including Lemonaid Health (collectively, “23andMe”), and is intended to provide such customers with additional information to assist in determining if you have a claim and filing proofs of claim. This notice will also be filed with the Court and accessible via the public docket. Receipt of this notice does not necessarily mean that you have a claim.


There are two claim packages (each, a “Bar Date Package” and collectively, the “Bar Date Packages”): the General Bar Date Package and the Cyber Security Incident Bar Date Package.


IF YOU ARE RECEIVING THIS NOTICE AND BELIEVE YOU HAVE A CLAIM AGAINST ANY DEBTOR, YOU MUST SUBMIT THE APPLICABLE PROOF OF CLAIM FORMS IN ACCORDANCE WITH THE INSTRUCTIONS SET FORTH BELOW ON OR BEFORE JULY 14, 2025.


THE FAILURE TO TIMELY SUBMIT ANY PROOF OF CLAIM ON OR BEFORE JULY 14, 2025 MAY RESULT IN THE WAIVER OF YOUR RIGHT TO ASSERT YOUR CLAIMS AGAINST THE DEBTORS AND YOUR RIGHT TO DISTRIBUTIONS ON ACCOUNT OF ANY SUCH CLAIMS UNDER A CHAPTER 11 PLAN IN THESE CASES.


Each of the Bar Date Packages correspond to a specific type of claim. The following instructions are provided to determine which Bar Date Package applies to you:

  • Cyber Security Incident Bar Date Package. This package applies only if (i) you were a customer of 23andMe between May 1, 2023 and October 1, 2023, (ii) you received notice from 23andMe that your personal information was compromised in a data breach that was discovered and disclosed by 23andMe in October 2023 (the “Cyber Security Incident”), and (iii) you incurred monetary damages or non- monetary damages related to the Cyber Security Incident. In that case, you may hold a cyber security incident claim (a “Cyber Security Incident Claim”) and are a potential “Cyber Security Incident Claimant.” The Cyber Security Incident Notice, included herein as part of the Cyber Security Bar Date Package, provides instructions you must follow to submit this type of claim.

  • General Bar Date Package. This package applies if you believe that you have any other claim against 23andMe and/or its subsidiaries that is nota Cyber Security Incident Claim. The General Bar Date Notice, included herein as part of the General Bar Date Package, provides instructions you must follow to submit this type of claim.

    • If you believe you have a claim arising from or related to the Debtors’ DNA testing services (i.e., Ancestry Service, Health + Ancestry Service, 23andMe+ Premium and 23andMe+ Total Health), the Debtors advise that 23andMe, Inc. is the primary Debtor entity engaged in that line of business.

    • If you believe you have a claim arising from or related to the Debtors’ telehealth business, the Debtors advise that Lemonaid Health, Inc.is the primary Debtor entity engaged in that line of business.

    • If you believe you have a claim arising from or related to the Debtors’ mail order pharmacy, the Debtors advise that LPRXOne, LLC is the primary Debtor entity engaged in that line of business.

  • If you believe that you have a Cyber Security Incident Claim and any other type of claim against the Debtors, you must submit separate claims for your Cyber Security Incident Claim and any such other claim in accordance with the instructions below.


Additional information for customers who believe they have a Cyber Security Incident Claim: Please note that a settlement has been preliminarily and conditionally approved in the multidistrict litigation currently pending before the Honorable Edward M. Chen in the United States District Court for the Northern District of California, MDL No. 3098 (the “Cyber Class Action”). The Cyber Class Action is currently stayed as a result of these chapter 11 cases, not final, and the Debtors have not made a decision (and reserve all rights) with respect to the treatment of the prepetition settlement of the Cyber Class Action in these cases. To fully preserve your claim(s), a proof of claim must be submitted in accordance with the instructions provided in the Cyber Security Bar Date Package. Failure to do so may result in a waiver of your participation in any distributions on account of your Cyber Security Incident Claim.


Additional information regarding 23andMe’s Chapter 11 filing, proceedings and claims process is available at https://restructuring.ra.kroll.com/23andMe. Questions about the claims process should be directed to the Company’s claims agent, Kroll, at 23andMeInfo@ra.kroll.com, or by calling (888) 367-7556 (Toll-Free in US/Canada) or +1 (646) 891-5055 (International).


Nothing herein is an admission as to the amount of, basis for, or validity of any claim against any Debtor entity and all rights of the Debtors and other parties in interest are fully preserved as to any potential claims and proofs of claims filed in these chapter 11 cases.

 
 
bottom of page